correction which typically retraces 61.8% would be huge. But this is a biotech and many biotechs simply fail. DYODD.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
